标题
Protective role of sulphoraphane against vascular complications in diabetes
作者
关键词
-
出版物
PHARMACEUTICAL BIOLOGY
Volume 54, Issue 10, Pages 2329-2339
出版商
Informa UK Limited
发表日期
2016-02-03
DOI
10.3109/13880209.2016.1138314
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Involvement of Toxic AGEs (TAGE) in the Pathogenesis of Diabetic Vascular Complications and Alzheimer's Disease
- (2017) Masayoshi Takeuchi et al. JOURNAL OF ALZHEIMERS DISEASE
- Protective Role of Sodium–Glucose Co-Transporter 2 Inhibition Against Vascular Complications in Diabetes
- (2016) Sho-ichi Yamagishi et al. REJUVENATION RESEARCH
- Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition
- (2015) Stephanie M. Tortorella et al. ANTIOXIDANTS & REDOX SIGNALING
- Neuroprotective Effect of Sulforaphane against Methylglyoxal Cytotoxicity
- (2015) Cristina Angeloni et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Natural Nrf2 activators in diabetes
- (2015) Angélica Saraí Jiménez-Osorio et al. CLINICA CHIMICA ACTA
- The intake of broccoli sprouts modulates the inflammatory and vascular prostanoids but not the oxidative stress-related isoprostanes in healthy humans
- (2015) Sonia Medina et al. FOOD CHEMISTRY
- Association Between 7 Years of Intensive Treatment of Type 1 Diabetes and Long-term Mortality
- (2015) Trevor J. Orchard et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clinical and Biochemical Factors Associated With Area and Metabolic Activity in the Visceral and Subcutaneous Adipose Tissues by FDG-PET/CT
- (2015) Nobuhiro Tahara et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Sulforaphane attenuation of experimental diabetic nephropathy involves GSK-3 beta/Fyn/Nrf2 signaling pathway
- (2015) Guoguo Shang et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Anti-inflammatory therapies for atherosclerosis
- (2015) Magnus Bäck et al. Nature Reviews Cardiology
- The emerging role of redox-sensitive Nrf2–Keap1 pathway in diabetes
- (2015) Elango Bhakkiyalakshmi et al. PHARMACOLOGICAL RESEARCH
- Role of Receptor for Advanced Glycation End Products (RAGE) and Its Ligands in Cancer Risk
- (2015) Sho-ichi Yamagishi et al. REJUVENATION RESEARCH
- Sulforaphane protected the injury of human vascular endothelial cell induced by LPC through up-regulating endogenous antioxidants and phase II enzymes
- (2015) Baolong Li et al. Food & Function
- Antithrombotic activities of sulforaphane via inhibiting platelet aggregation and FIIa/FXa
- (2014) Sae-Kwang Ku et al. ARCHIVES OF PHARMACAL RESEARCH
- Advanced glycation end products potentiate citrated plasma-evoked oxidative and inflammatory reactions in endothelial cells by up-regulating protease-activated receptor-1 expression
- (2014) Yuji Ishibashi et al. Cardiovascular Diabetology
- Molecular Imaging of Vascular Inflammation
- (2014) Nobuhiro Tahara et al. CURRENT PHARMACEUTICAL DESIGN
- Role of AGEs-RAGE System in Cardiovascular Disease
- (2014) Kei Fukami et al. CURRENT PHARMACEUTICAL DESIGN
- Ratio of Serum Levels of AGEs to Soluble Form of RAGE Is a Predictor of Endothelial Function
- (2014) Masato Kajikawa et al. DIABETES CARE
- Sulforaphane Inhibits TNF-α-Induced Adhesion Molecule Expression Through the Rho A/ROCK/NF-κB Signaling Pathway
- (2014) Chi-Nan Hung et al. JOURNAL OF MEDICINAL FOOD
- Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway
- (2014) Zhiguo Zhang et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Sulforaphane reduces vascular inflammation in mice and prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway
- (2014) Palanisamy Nallasamy et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Sulforaphane inhibits advanced glycation end product–induced pericyte damage by reducing expression of receptor for advanced glycation end products
- (2014) Sayaka Maeda et al. NUTRITION RESEARCH
- Sulforaphane inhibits endothelial protein C receptor shedding in vitro and in vivo
- (2014) Sae-Kwang Ku et al. VASCULAR PHARMACOLOGY
- Antiplatelet activity of L-sulforaphane by regulation of platelet activation factors, glycoprotein IIb/IIIa and thromboxane A2
- (2013) Chung-Hun Oh et al. BLOOD COAGULATION & FIBRINOLYSIS
- Relationship between Advanced Glycation End Products and Plaque Progression in Patients with Acute Coronary Syndrome: The JAPAN-ACS Sub-study
- (2013) Yoshifumi Fukushima et al. Cardiovascular Diabetology
- Defective Nrf2-dependent redox signalling contributes to microvascular dysfunction in type 2 diabetes
- (2013) Gopal V. Velmurugan et al. CARDIOVASCULAR RESEARCH
- Advanced Glycation End Products (AGE) and Diabetes: Cause, Effect, or Both?
- (2013) Helen Vlassara et al. Current Diabetes Reports
- The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview
- (2013) David M. Nathan et al. DIABETES CARE
- Sulforaphane enhances the activity of the Nrf2–ARE pathway and attenuates inflammation in OxyHb-induced rat vascular smooth muscle cells
- (2013) X.-D. Zhao et al. INFLAMMATION RESEARCH
- Radical Roles for RAGE in the Pathogenesis of Oxidative Stress in Cardiovascular Diseases and Beyond
- (2013) Gurdip Daffu et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation
- (2013) Yang Bai et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Effects of bioactive-rich extracts of pomegranate, persimmon, nettle, dill, kale andSideritisand isolated bioactives on arachidonic acid induced markers of platelet activation and aggregation
- (2013) Aleksandra Konić-Ristić et al. JOURNAL OF THE SCIENCE OF FOOD AND AGRICULTURE
- Blockade by phosphorothioate aptamers of advanced glycation end products-induced damage in cultured pericytes and endothelial cells
- (2013) Yuichiro Higashimoto et al. MICROVASCULAR RESEARCH
- Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidylinositol 3-kinase/Akt pathway
- (2013) Wen-Ying Chuang et al. THROMBOSIS AND HAEMOSTASIS
- Sulforaphane inhibits PDGF-induced proliferation of rat aortic vascular smooth muscle cell by up-regulation of p53 leading to G1/S cell cycle arrest
- (2013) Su-Hyang Yoo et al. VASCULAR PHARMACOLOGY
- Glucagon-Like Peptide-1 Receptor Agonist Inhibits Asymmetric Dimethylarginine Generation in the Kidney of Streptozotocin-Induced Diabetic Rats by Blocking Advanced Glycation End Product–Induced Protein Arginine Methyltranferase-1 Expression
- (2012) Ayako Ojima et al. AMERICAN JOURNAL OF PATHOLOGY
- Sulforaphane inhibits restenosis by suppressing inflammation and the proliferation of vascular smooth muscle cells
- (2012) Jin-Sook Kwon et al. ATHEROSCLEROSIS
- Enhanced Nrf2 Activity Worsens Insulin Resistance, Impairs Lipid Accumulation in Adipose Tissue, and Increases Hepatic Steatosis in Leptin-Deficient Mice
- (2012) J. Xu et al. DIABETES
- Positive Association Between Serum Level of Glyceraldehyde-Derived Advanced Glycation End Products and Vascular Inflammation Evaluated by [18F]Fluorodeoxyglucose Positron Emission Tomography
- (2012) N. Tahara et al. DIABETES CARE
- Diabetes and life expectancy among Japanese – NIPPON DATA80
- (2012) Tanvir Chowdhury Turin et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Effect of broccoli sprouts on insulin resistance in type 2 diabetic patients: a randomized double-blind clinical trial
- (2012) Zahra Bahadoran et al. INTERNATIONAL JOURNAL OF FOOD SCIENCES AND NUTRITION
- Metabolic Effects of Sulforaphane Oral Treatment in Streptozotocin-Diabetic Rats
- (2012) Carolina Guerini de Souza et al. JOURNAL OF MEDICINAL FOOD
- A novel antithrombotic effect of sulforaphane via activation of platelet adenylate cyclase: ex vivo and in vivo studies
- (2012) Thanasekaran Jayakumar et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Prevention of Diabetic Nephropathy by Sulforaphane: Possible Role of Nrf2 Upregulation and Activation
- (2012) Wenpeng Cui et al. Oxidative Medicine and Cellular Longevity
- Potential Clinical Utility of Advanced Glycation End Product Cross-Link Breakers in Age- and Diabetes-Associated Disorders
- (2012) Sho-ichi Yamagishi REJUVENATION RESEARCH
- Glucosinolates and isothiocyanates in health and disease
- (2012) Albena T. Dinkova-Kostova et al. TRENDS IN MOLECULAR MEDICINE
- Serum Levels of Advanced Glycation End Products (AGEs) are Inversely Associated with the Number and Migratory Activity of Circulating Endothelial Progenitor Cells in Apparently Healthy Subjects
- (2011) So Ueda et al. Cardiovascular Therapeutics
- Role of Advanced Glycation End Products (AGEs) in Osteoporosis in Diabetes
- (2011) Sho-ichi Yamagishi CURRENT DRUG TARGETS
- Nrf2 and NF-κB Modulation by Sulforaphane Counteracts Multiple Manifestations of Diabetic Neuropathy in Rats and High Glucose-Induced Changes
- (2011) Geeta Negi et al. CURRENT NEUROVASCULAR RESEARCH
- Phytochemicals Resveratrol and Sulforaphane as Potential Agents for Enhancing the Anti-Tumor Activities of Conventional Cancer Therapies
- (2011) Bettina M. Kaminski et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
- (2011) Hongting Zheng et al. DIABETES
- Estimated morbidity and mortality in adolescents and young adults diagnosed with Type 2 diabetes mellitus
- (2011) E. T. Rhodes et al. DIABETIC MEDICINE
- Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
- (2011) NEW ENGLAND JOURNAL OF MEDICINE
- Sulforaphane suppresses vascular adhesion molecule-1 expression in TNF-α-stimulated mouse vascular smooth muscle cells: Involvement of the MAPK, NF-κB and AP-1 signaling pathways
- (2011) Ji-Yun Kim et al. VASCULAR PHARMACOLOGY
- The inhibition of autophagy potentiates anti-angiogenic effects of sulforaphane by inducing apoptosis
- (2010) Takeshi Nishikawa et al. ANGIOGENESIS
- Sulforaphane inhibits endothelial lipase expression through NF-κB in endothelial cells
- (2010) Annukka M. Kivelä et al. ATHEROSCLEROSIS
- Serum Levels of Advanced Glycation End Products (AGEs) are Independent Correlates of Insulin Resistance in Nondiabetic Subjects
- (2010) Nobuhiro Tahara et al. Cardiovascular Therapeutics
- Protective Effect of Sulforaphane on Human Vascular Endothelial Cells Against Lipopolysaccharide-Induced Inflammatory Damage
- (2010) Yujuan Shan et al. Cardiovascular Toxicology
- Anti-Atherothrombogenic Properties of PEDF
- (2010) S.-I. Yamagishi et al. CURRENT MOLECULAR MEDICINE
- Protective effect of sulforaphane against oxidative stress: Recent advances
- (2010) Carlos Enrique Guerrero-Beltrán et al. EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
- Sulphoraphane inhibited the expressions of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 through MyD88-dependent toll-like receptor-4 pathway in cultured endothelial cells
- (2010) Y. Shan et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Activation of Nrf2 in Endothelial Cells Protects Arteries From Exhibiting a Proinflammatory State
- (2009) Mustafa Zakkar et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Glucagon-like peptide-1 (GLP-1) inhibits advanced glycation end product (AGE)-induced up-regulation of VCAM-1 mRNA levels in endothelial cells by suppressing AGE receptor (RAGE) expression
- (2009) Yuji Ishibashi et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy – are these Receptors Valid Therapeutic Targets
- (2009) Karly Sourris et al. CURRENT DRUG TARGETS
- Pigment epithelium-derived factor (PEDF) prevents platelet activation and aggregation in diabetic rats by blocking deleterious effects of advanced glycation end products (AGEs)
- (2009) Sho-Ichi Yamagishi et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Sulforaphane inhibits TNF-α-induced activation of p38 MAP kinase and VCAM-1 and MCP-1 expression in endothelial cells
- (2009) Xi-Lin Chen et al. INFLAMMATION RESEARCH
- Sulforaphane Stimulates Activation of Proapoptotic Protein Bax Leading to Apoptosis of Endothelial Progenitor Cells
- (2008) Takeshi Nishikawa et al. ANNALS OF SURGICAL ONCOLOGY
- Sensory Neurons and Schwann Cells Respond to Oxidative Stress by Increasing Antioxidant Defense Mechanisms
- (2008) Andrea M. Vincent et al. ANTIOXIDANTS & REDOX SIGNALING
- Potent Induction of Total Cellular and Mitochondrial Antioxidants and Phase 2 Enzymes by Cruciferous Sulforaphane in Rat Aortic Smooth Muscle Cells: Cytoprotection Against Oxidative and Electrophilic Stress
- (2008) Hong Zhu et al. Cardiovascular Toxicology
- Role of Oxidative Stress in the Development of Vascular Injury and its Therapeutic Intervention by Nifedipine
- (2008) Sho-ichi Yamagishi et al. CURRENT MEDICINAL CHEMISTRY
- Activation of NF-E2-Related Factor-2 Reverses Biochemical Dysfunction of Endothelial Cells Induced by Hyperglycemia Linked to Vascular Disease
- (2008) M. Xue et al. DIABETES
- A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane-bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)
- (2008) Angela Raucci et al. FASEB JOURNAL
- The diet-derived sulforaphane inhibits matrix metalloproteinase-9-activated human brain microvascular endothelial cell migration and tubulogenesis
- (2008) Borhane Annabi et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Sulforaphane inhibition of monocyte adhesion via the suppression of ICAM-1 and NF-κB is dependent upon glutathione depletion in endothelial cells
- (2008) Yen-Chin Liu et al. VASCULAR PHARMACOLOGY
- Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes
- (2007) Kazuo Nakamura et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started